$APOLLOHOSP Apollo Hospitals Enterprise Ltd announced strong Q4 FY26 results today (20 May 2026

Apollo Hospitals Enterprise Ltd announced strong Q4 FY26 results today (20 May 2026), with consolidated net profit rising 36 % YoY to ₹529 crore, revenue up 18 % to ₹6,606 crore, and a ₹10 per‑share final dividend declared. The record date for the dividend is 14 August 2026, and payment will be made on or before 10 September 2026 Apollo Hospitals Q4 FY26 Financial Highlights Metric Q4 FY26 YoY Change Notes Revenue from Operations ₹6,606 crore ▲ 18 % Driven by higher patient volumes and digital health services. EBITDA ₹1,011 crore ▲ 26 % Margin improved to 15.3 % vs 14.4 % last year. Net Profit (PAT) ₹529 crore ▲ 36 % Beat Street estimates of ₹452 crore. EPS ₹37.8 vs  ₹27.8 last year Reflects strong profitability. Dividend ₹10 per share (200 %) — Record Date 14 Aug 2026; Payment by 10 Sep 2026. Segment Performance Healthcare Services: Revenue ₹3,268 crore (↑ 16 % YoY). EBITDA ₹781 crore (↑ 14 %), margin 23.9 %. PAT ₹412 crore (↑ 7 %). Apollo Health & Lifestyle: Revenue ₹489 crore (↑ 24 %). EBITDA ₹75 crore (↑ 58 %), margin 15.3 %. PAT ₹10 crore (vs loss ₹4 crore last year). Apollo HealthCo (Digital & Pharmacy): Revenue ₹2,848 crore (↑ 20 %). EBITDA ₹156 crore (vs ₹36 crore last year). PAT ₹107 crore (vs ₹9 crore last year). Management Commentary Dr Prathap C Reddy re‑appointed as Executive Chairman for two years from 25 June 2026. Focus on digital expansion, preventive care, and international patient services. Plans to divest stakes in Apollo Specialty and Apollo Fertility to Kids Clinic India for ~₹1,550 crore enterprise value.